Target Information
Extens has announced the acquisition of a majority stake in Imagine Human, a leading French company specializing in Prevention (HSE) and Quality of Work Life (QVCT). Founded over 20 years ago and previously owned by the family office Evolem, Imagine Human is chaired by Yannick Jarlaud. The company currently employs over 50 professionals and serves more than 1,500 clients, impacting over 4 million employees with its innovative solutions, WinLassie® and ForMe®.
WinLassie® is recognized as a key software platform for risk management and HSE (Health, Safety, and Environment) issues, making it suitable for companies of all sizes across various sectors. As demand for Quality of Work Life continues to grow, Imagine Human stands out as a pivotal player in this market.
Industry Overview in France
The French market for Quality of Work Life and Occupational Health has been witnessing significant transformation, driven by increasing awareness surrounding employee well-being and regulatory standards. The human resources sector identifies this area as a critical priority, with approximately 75% of professionals recognizing it as a major concern for their teams.
Over the past five years, there has been a substantial shift in how organizations approach workplace safety and employee satisfaction. With an increase in remote work arrangements and the changing landscape of employee expectations, companies are focusing more on innovative solutions that enhance Quality of Work Life.
This evolving market presents opportunities for disruptive companies like Imagine Human to capture market share, as they challenge traditional approaches with new technologies and methodologies. Consequently, organizations are more inclined to invest in modern software solutions that address these new challenges.
The emergence of tech-driven tools in workplace health management not only supports compliance but also promotes a culture of well-being. As a result, businesses focusing on enhancing QVCT are likely to see better employee engagement and retention, shaping the future of work in France.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Rationale Behind the Deal
Extens’s investment in Imagine Human is primarily strategic, aimed at furthering the company’s capacity to lead in the QVCT space both in France and internationally. The funds and operational expertise provided by Extens will enable Imagine Human to enhance its offerings and support the expansion of WinLassie®.
The increasing demand for Quality of Work Life solutions provides a favorable landscape for Imagine Human’s continued growth. Extens aims to leverage this momentum to solidify and expand Imagine Human’s market position.
Information About the Investor
Extens is a specialized investment fund focusing on healthcare software and data, recognized for its strategic acquisitions aimed at fostering growth and innovation within its portfolio companies. The firm is committed to supporting companies that align with its mission of advancing healthcare solutions, particularly in areas that enhance operational efficiency and overall well-being.
By partnering with companies like Imagine Human, Extens seeks to contribute to the evolution of employee wellness solutions, enabling them to become leaders in their respective markets. The investment reflects Extens’s confidence in Imagine Human’s potential to meet the growing challenges of workplace health and safety.
View of Dealert
The acquisition of Imagine Human by Extens appears to be a strategic and potentially lucrative investment. With the increasing emphasis on Quality of Work Life in the contemporary workforce, Imagine Human is well-positioned to take advantage of this trend. The company's strong market presence and reputable software solutions give it a competitive edge in the industry.
Moreover, the operational support from Extens is likely to catalyze the expansion and enhancement of Imagine Human’s product offerings, making it an attractive proposition for existing and future clients. The focus on both organic growth and external expansion bodes well for the company’s long-term success.
In conclusion, Extens’s acquisition aligns with current market demands and positions both parties for a promising future. If executed effectively, this deal could enhance Imagine Human’s innovation capacity and market influence, ultimately benefitting employees and organizations alike.
Similar Deals
Edmond de Rothschild Equity Strategies IV SLP → M-Energies
2025
FIDUCIAL Expertise → Ariane, Sogeca Run, Neo Expert
2024
Extens
invested in
Imagine Human
in 2024
in a Buyout deal